Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleiotropy01:33

Pleiotropy

40.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.4K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study protocol for FAXAge: a randomized, controlled clinical trial of fasting and exercise to slow aging in humans.

GeroScience·2026
Same author

The mitochondrial unfolded protein response in human microglia disrupts neuronal-glial communication and promotes senescence.

Nature neuroscience·2026
Same author

Delphi-derived Framework for Healthspan-Oriented Care: The Cardiometabolic Health Perspective.

Aging and disease·2026
Same author

Integrating AI and Causal Genetics to Prioritize Therapeutic Targets for Aging and Age-Related Diseases.

Aging and disease·2026
Same author

Novel drug targets in 2025.

Nature reviews. Drug discovery·2026
Same author

Lessons From Drug Discovery for Cryoprotective Agent Design: An AI-Oriented Perspective.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Short-term responsiveness of DNA methylation-based aging biomarkers to a multimodal intervention comprising exercise and dietary guidance involving daily consumption of yogurt containing <i>Bifidobacterium longum</i> BB536: an exploratory randomized controlled trial.

Aging·2026
Same journal

Hormonal dimorphism in sarcopenia disease.

Aging·2026
Same journal

The multifaceted inducers of cellular senescence.

Aging·2026
Same journal

Life expectancy and causes of death in classical laminopathic progeroid syndromes: systematic review with individual-patient data synthesis.

Aging·2026
Same journal

Age-related dysfunctions of the neuroendocrine axes in nonhuman primates with depression-like and anxious behavior.

Aging·2026
Same journal

The love and hate relationship between cellular senescence and stemness.

Aging·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2025

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

716

Defining the progeria phenome.

Cecilie Worm1, Maya Elena Ramirez Schambye1, Garik V Mkrtchyan1

  • 1Center for Healthy Aging, Department of Cellular and Molecular Medicine, University of Copenhagen, Denmark.

Aging
|February 12, 2024
PubMed
Summary
This summary is machine-generated.

This study defines the 'progeria phenome' to aid in diagnosing rare premature aging disorders. A new machine learning tool classifies progerias, identifying potential new cases and improving understanding of these complex conditions.

Keywords:
agingclinical phenotypephenomepremature agingprogeria

More Related Videos

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
09:18

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

2.9K
Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.3K

Related Experiment Videos

Last Updated: Jul 3, 2025

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

716
Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans
09:18

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

2.9K
Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

6.3K

Area of Science:

  • Genetics
  • Computational Biology
  • Rare Diseases

Background:

  • Progeroid disorders are rare, heterogeneous hereditary syndromes with diverse phenotypes resembling normal aging.
  • Clinical variability presents diagnostic challenges, hindering research into these premature aging conditions.

Purpose of the Study:

  • To develop a computational tool for classifying progeroid syndromes.
  • To identify potential novel progeroid syndromes through data analysis.
  • To enhance the understanding and diagnosis of premature aging disorders.

Main Methods:

  • Compiled a dataset of known progeroid syndromes and their associated phenotypes.
  • Calculated mean phenotype prevalence to define the 'progeria phenome'.
  • Trained a support vector machine classifier and utilized hierarchical clustering with disease networks.

Main Results:

  • Developed a machine learning tool (available at https://www.mitodb.com) for progeria classification based on phenotypes.
  • Identified strong associations between ataxia-telangiectasia like disorder 2, spastic paraplegia 49, and Meier-Gorlin syndrome with progeroid syndromes.
  • These findings suggest these syndromes may be previously unrecognized forms of progeria.

Conclusions:

  • The study provides novel tools to assess the likelihood of a syndrome or patient being progeroid.
  • This represents a significant advancement in the diagnosis and understanding of premature aging disorders.
  • The 'progeria phenome' concept aids in characterizing and identifying these rare conditions.